ResearcherGerman Cancer Research CenterActive in the last 2 years
Hanno Glimm
Matched on ORCID iD 0000-0003-4104-1135; OpenAlex author ID A5061578149, A5112382510. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 0, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 22
2016: 1 paper · 2017: 1 paper · 2018: 1 paper · 2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper
Papers 5
- 17.6% of patients in a German cohort with exocrine pancreatic cancer were diagnosed with a genetic tumor syndrome-a case for universal genetic testing? Co-author DOI 10.1016/j.esmogo.2025.100218↗
- Systematic Generation of Patient-Derived Tumor Models in Pancreatic Cancer. Co-author DOI 10.3390/cells8020142↗
- NRG1 Fusions in KRAS Wild-Type Pancreatic Cancer. Last author DOI 10.1158/2159-8290.cd-18-0036↗
- Succession of transiently active tumor-initiating cell clones in human pancreatic cancer xenografts. Last author DOI 10.15252/emmm.201607354↗
- Identification of a tumor-reactive T-cell repertoire in the immune infiltrate of patients with resectable pancreatic ductal adenocarcinoma. Co-author DOI 10.1080/2162402x.2016.1240859↗
Closest collaborators
The 22 strongest of 22 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Karl Roland Ehrenberg · 3 shared papers, 2017–2019 · strength 0.17
- Paper Systematic Generation of Patient-Derived Tumor Models in Pancreatic Cancer. DOI 10.3390/cells8020142↗
- Paper Succession of transiently active tumor-initiating cell clones in human pancreatic cancer xenografts. DOI 10.15252/emmm.201607354↗
- Paper NRG1 Fusions in KRAS Wild-Type Pancreatic Cancer. DOI 10.1158/2159-8290.cd-18-0036↗
- Claudia R. Ball · 3 shared papers, 2017–2019 · strength 0.17
- Paper Systematic Generation of Patient-Derived Tumor Models in Pancreatic Cancer. DOI 10.3390/cells8020142↗
- Paper Succession of transiently active tumor-initiating cell clones in human pancreatic cancer xenografts. DOI 10.15252/emmm.201607354↗
- Paper NRG1 Fusions in KRAS Wild-Type Pancreatic Cancer. DOI 10.1158/2159-8290.cd-18-0036↗
- Oliver Strobel · 3 shared papers, 2016–2019 · strength 0.17
- Paper Systematic Generation of Patient-Derived Tumor Models in Pancreatic Cancer. DOI 10.3390/cells8020142↗
- Paper NRG1 Fusions in KRAS Wild-Type Pancreatic Cancer. DOI 10.1158/2159-8290.cd-18-0036↗
- Paper Identification of a tumor-reactive T-cell repertoire in the immune infiltrate of patients with resectable pancreatic du… DOI 10.1080/2162402x.2016.1240859↗
- Jürgen Weitz · 2 shared papers, 2017–2019 · strength 0.12
- Wilko Weichert · 2 shared papers, 2017–2018 · strength 0.10
- Thilo Hackert · 2 shared papers, 2016–2018 · strength 0.09
- Moritz Koch · 1 shared paper, 2017 · strength 0.05
- Jens Werner · 1 shared paper, 2017 · strength 0.05
- Nathalia A. Giese · 1 shared paper, 2018 · strength 0.05
- Christoph Heining · 1 shared paper, 2018 · strength 0.05
- Marius Horger · 1 shared paper, 2018 · strength 0.05
- Christoph Springfeld · 1 shared paper, 2018 · strength 0.05
- Albrecht Stenzinger · 1 shared paper, 2018 · strength 0.05
- Michael Volkmar · 1 shared paper, 2016 · strength 0.04
- Rienk Offringa · 1 shared paper, 2016 · strength 0.04
- Thomas P. Hank · 1 shared paper, 2016 · strength 0.04
- Martin Ronald Sprick · 1 shared paper, 2016 · strength 0.04
- Markus Wolfgang Büchler · 1 shared paper, 2016 · strength 0.04
- Isabel C. Poschke · 1 shared paper, 2016 · strength 0.04
- Andreas Trumpp · 1 shared paper, 2016 · strength 0.04
- Niels Halama · 1 shared paper, 2016 · strength 0.04
- Uğur Şahin · 1 shared paper, 2016 · strength 0.04
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.